Eli Lilly to Purchase Morphic, Green Hydrogen
Bloomberg Intelligence
Intro
Exploring Eli Lilly's recent purchase of Morphic, a company specializing in gastrointestinal health, with insights from Sam Vazelli, Bloomberg Intelligence's Director of Research for Global Industries and Pharmaceuticals.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
